. He can be reached at nsaraceno@mjhlifesciences.com.

Videos

In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, outlines strategies that companies can adopt to help mitigate these increasing costs.

How to Manage Rising Drug Development Costs

Articles

Pharma Pulse 5/16/25: A Closer Look at NIH Grant Terminations; Simulated Pre-Launch Market Evaluation in the Modern Pharmaceutical Industry

Ruth Beadle, head, global supply chain, Sanofi, explains how the company balances daily operations with long-term transformation efforts to ensure timely delivery of critical medications to patients.

LogiPharma Europe 2025: Inside the Daily Workflow of Sanofi’s Global Supply Chain Head

A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.

Themes Among Rare Disease Repurposing Efforts

Pharma Pulse 5/15/25: Five Questions on Trump’s Plan to Lower US Drug Prices; Roche Reports Final Overall Survival Outcomes from Breast Cancer Treatment Trial

In the first part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, shares the key factors that he believes are propelling a continued rise in projected R&D ROI.  

The Positive Momentum Behind Pharma Innovation

Andrew Witty resigns due to personal reasons, as Stephen Hemsley, chairman and former chief executive, will assume the position.

UnitedHealth Group CEO Departs

Pharma Pulse 5/14/25: Bluebird Bio Warns of Potential Bankruptcy as Buyout Faces Another Delay; Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs

Trump anticipates that the executive order will help lower drug prices by 30% to 80%.

White House Introduces Most Favored Nation EO


In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, discusses the obstacles in documenting and proving DSCSA compliance.

News